Do gamma delta T cells play an important role in autoimmune disease? 1991

B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
Max-Planck-Gesellschaft, Klinische Arbeitsgruppen für Rheumatologie am Institut für Klinische Immunologie der Universität Erlangen-Nürnberg, Germany.

A T cell subpopulation using an alternative receptor heterodimer (gamma delta T cells) contributes 0.5-10% to the T cell population in the normal peripheral blood. One subset of gamma delta T cells (V gamma 9+/V delta 2+/ C gamma 1) preferentially recognizes mycobacterial antigens, which are the triggering antigens in the rat adjuvant arthritis (AA), an animal model with some similarities with rheumatoid arthritis (RA). Here we summarize data on the prevalence of gamma delta T cells in peripheral blood, synovial fluid and synovial membranes of RA patients which show that gamma delta T cells, in particular the subset reactive with mycobacterial antigens in normal individuals, are rare in all studied compartments. Furthermore, there was no enrichment of gamma delta T cells in the peripheral blood of patients with ankylosing spondylitis or systemic lupus erythematosus, autoimmune diseases with involvement of the joints. In the AA model depletion of the "conventional" alpha beta T cells completely prevented the induction of the disease and very effectively improved ongoing arthritis even though substantial numbers of gamma delta T cells were present in these animals. Taken together, our data do not support the notion of a significant contribution of gamma delta T cells to chronic joint inflammation in the autoimmune diseases studied or in adjuvant arthritis.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
October 1999, Parasitology,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
September 1990, Research in immunology,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
February 2020, Cells,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
July 1995, Journal of immunology (Baltimore, Md. : 1950),
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
June 1996, Lancet (London, England),
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
November 1995, Transplantation,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
October 1990, Human cell,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
January 2002, Pathobiology : journal of immunopathology, molecular and cellular biology,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
May 1998, European journal of immunology,
B M Bröker, and M D Smith, and S Yoshino, and P M Lydyard, and F Emmrich
December 1994, Immunology,
Copied contents to your clipboard!